The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes with bendamustine lymphodepletion prior to brexucabtagene autoleucel for mantle cell lymphoma.
 
Elise A. Chong
Consulting or Advisory Role - BeiGene; Novartis; TG Therapeutics
Research Funding - Genentech/Roche
 
James N. Gerson
Research Funding - Loxo
 
Sunita Dwivedy Nasta
Honoraria - Acrotech Biopharma; Acrotech Biopharma
Consulting or Advisory Role - Incyte; Merck; MorphoSys
Research Funding - Aileron Therapeutics; Atara Biotherapeutics; Debiopharm Group; Forty Seven; Incyte; Millennium; Pharmacyclics/Janssen; Rafael Pharmaceuticals; Roche/Genentech
 
Daniel J Landsburg
Consulting or Advisory Role - ADC Therapeutics; Epizyme; Incyte; Karyopharm Therapeutics; MorphoSys
Speakers' Bureau - Seagen
Research Funding - Calithera Biosciences; Curis (Inst)
Other Relationship - Karyopharm Therapeutics
 
Stefan K. Barta
Honoraria - Acrotech Biopharma; Affimed Therapeutics; Daiichi Sankyo/Lilly; Janssen Oncology; Kyowa Kirin International; Seagen
Consulting or Advisory Role - Acrotech Biopharma
 
Jakub Svoboda
Consulting or Advisory Role - Adaptive Biotechnologies; AstraZeneca; Atara Biotherapeutics; BMS; Pharmacyclics; Seagen
Research Funding - Adaptive Biotechnologies (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst); TG Therapeutics (Inst)
 
Elizabeth Weber
No Relationships to Disclose
 
Emeline R. Chong
No Relationships to Disclose
 
Stephen J. Schuster
Consulting or Advisory Role - Acerta Pharma; BeiGene; Celgene; Genentech/Roche; Incyte; Janssen; Legend Biotech; Loxo; MorphoSys; MustangBio; Nordic Nanovector; Novartis; Regeneron
Research Funding - Abbvie; Adaptive Biotechnologies; Celgene; DTRM; Genentech/Roche; Incyte; Juno Therapeutics; Merck; Novartis; Pharmacyclics; TG Therapeutics